About Us
Overview
Corporate Governance
Board of Directors
Board Committees
Management
Legacy
Careers
Technology
DNA Technology
Formulations
Vaxfectin
®
Adjuvant
Poloxamer Delivery System
Grants
Publications
Products
Pipeline
Infectious Disease Vaccines
TransVax™
CyMVectin™
HSV-2 Vaccine
Apex
®
-IHN
HIV Vaccine
Dengue Vaccine
Cancer Immunotherapies
Allovectin
®
hTERT Vaccine
ONCEPT®
Angiogenesis
Collategene™
Clinical Trials
Overview & Active Programs
Investors
Overview
What's in Vical's DNA?
Stock Information
News Releases
Events & Presentations
SEC Filings
Briefcase
Fact Sheet
IR & Media Contacts
Contact Us
Contact Info
Directions to Vical
Careers
NASDAQ | VICL
:
3.58
+0.00
Investors
Overview
What's in Vical's DNA?
Stock Information
News Releases
Events & Presentations
SEC Filings
Briefcase
Fact Sheet
IR & Media Contacts
Overview
What's in Vical's DNA?
Stock Information
News Releases
Events & Presentations
SEC Filings
Briefcase
Fact Sheet
IR & Media Contacts
Home
/
Investors
/
SEC Filings
SEC Filings
All Form Types
Annual Filings
Quarterly Filings
Current Reports
Proxy Filings
Registration Statements
Section 16 Filings
Other Filings
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1990
1989
1988
1987
Date
Filing
Description
Download
November 28, 2012
4
Statement of Changes in Beneficial Ownership
November 28, 2012
4
Statement of Changes in Beneficial Ownership
November 7, 2012
424B5
Prospectus filed pursuant to Rule 424(b)(5)
November 7, 2012
10-Q
Quarterly Report
November 7, 2012
8-K
Current report filing
October 17, 2012
4
Statement of Changes in Beneficial Ownership
October 17, 2012
3
Initial Statement of Beneficial Ownership
October 16, 2012
8-K
Current report filing
October 11, 2012
4
Statement of Changes in Beneficial Ownership
October 11, 2012
4
Statement of Changes in Beneficial Ownership
October 9, 2012
4
Statement of Changes in Beneficial Ownership
August 31, 2012
CT ORDER
Confidential Treatment Order
August 10, 2012
S-8
Securities Registration: Employee Benefit Plan
August 8, 2012
10-Q
Quarterly Report
August 1, 2012
8-K
Current report filing
July 11, 2012
4
Statement of Changes in Beneficial Ownership
July 11, 2012
4
Statement of Changes in Beneficial Ownership
July 9, 2012
4
Statement of Changes in Beneficial Ownership
May 31, 2012
8-K
Current report filing
May 29, 2012
4
Statement of Changes in Beneficial Ownership
May 29, 2012
4
Statement of Changes in Beneficial Ownership
May 29, 2012
4
Statement of Changes in Beneficial Ownership
May 29, 2012
4
Statement of Changes in Beneficial Ownership
May 17, 2012
DEFA14A
Additional Proxy Soliciting Materials (definitive)
May 15, 2012
EFFECT
Effectiveness Order
May 15, 2012
424B3
Prospectus filed pursuant to Rule 424(b)(3)
May 4, 2012
S-3
Securities Registration Statement (simplified form)
May 2, 2012
10-Q
Quarterly Report
May 2, 2012
8-K
Current report filing
April 13, 2012
DEFA14A
Additional Proxy Soliciting Materials (definitive)
April 13, 2012
DEF 14A
Proxy Statement (definitive)
April 12, 2012
4
Statement of Changes in Beneficial Ownership
April 12, 2012
4
Statement of Changes in Beneficial Ownership
April 9, 2012
4
Statement of Changes in Beneficial Ownership
March 15, 2012
10-K
Annual Report
February 14, 2012
SC 13G
Statement of Ownership
February 13, 2012
SC 13G/A
Amended Statement of Ownership
February 10, 2012
SC 13G/A
Amended Statement of Ownership
February 9, 2012
SC 13G/A
Amended Statement of Ownership
February 8, 2012
SC 13G/A
Amended Statement of Ownership
February 8, 2012
8-K
Current report filing
February 2, 2012
CT ORDER
Confidential Treatment Order
January 18, 2012
4
Statement of Changes in Beneficial Ownership
January 18, 2012
4
Statement of Changes in Beneficial Ownership
January 18, 2012
4
Statement of Changes in Beneficial Ownership
January 12, 2012
4
Statement of Changes in Beneficial Ownership
January 12, 2012
4
Statement of Changes in Beneficial Ownership
January 11, 2012
SC 13G/A
Amended Statement of Ownership
January 10, 2012
4
Statement of Changes in Beneficial Ownership
January 10, 2012
SC 13G/A
Amended Statement of Ownership
January 9, 2012
4
Statement of Changes in Beneficial Ownership
January 9, 2012
8-K
Current report filing
January 6, 2012
424B5
Prospectus filed pursuant to Rule 424(b)(5)
January 6, 2012
424B5
Prospectus filed pursuant to Rule 424(b)(5)
January 6, 2012
4
Statement of Changes in Beneficial Ownership
January 6, 2012
3
Initial Statement of Beneficial Ownership
January 5, 2012
424B5
Prospectus filed pursuant to Rule 424(b)(5)
January 5, 2012
424B5
Prospectus filed pursuant to Rule 424(b)(5)
January 5, 2012
8-K
Current report filing
January 5, 2012
4
Statement of Changes in Beneficial Ownership
CONNECT WITH US
RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube
About Us
Overview
Corporate Governance
Board of Directors
Board Committees
Management
Legacy
Careers
Technology
DNA Technology
Formulations
Vaxfectin
®
Adjuvant
Poloxamer Delivery System
Grants
Publications
Products
Pipeline
Infectious Disease Vaccines
TransVax™
CyMVectin™
HSV-2 Vaccine
Apex
®
-IHN
HIV Vaccine
Dengue Vaccine
Cancer Immunotherapies
Allovectin
®
hTERT Vaccine
ONCEPT®
Angiogenesis
Collategene™
Clinical Trials
Overview & Active Programs
Investors
Overview
What's in Vical's DNA?
Stock Information
News Releases
Events & Presentations
SEC Filings
Briefcase
Fact Sheet
IR & Media Contacts
Contact Us
Contact Info
Directions to Vical
Careers
CONNECT WITH US
RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube
© 2013 Vical Inc.
Privacy Policy
Terms of Use
Site Map
P. 858 646 1100
10390 Pacific Center Court, San Diego, California 92121
Designed by
Mentus
Powered By Q4 Web Systems
3.8.1.5343
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.